BSKB News

Learn about BSKB’s announcements, recognitions, and other firm news below.

  • May 8, 2020

    Charles Gorenstein Quoted in E Commerce Times on President Obama’s Comments on Patent Trolls

    Charles Gorenstein, partner at BSKB, was quoted in a June 5, 2013 E Commerce Times article regarding Obama administrations targeting of patent trolls with a number of initiatives aimed at curbing activity it blames for stymieing innovation in America. Patent trolls have been accused of abusing the system to squeeze money from just about anyone using technology containing their intellectual property. However, they’ve also been praised for protecting small inventors from being crushed by corporations.

  • May 8, 2020

    CAFC Reverses USPTO Ruling on Leo Pharma Patent

    The Federal Circuit reversed a USPTO decision of obviousness and claim construction on Leo Pharmaceutical Products Ltd.’s psoriasis drug patent on Monday, August 12, 2013. The Federal Circuit’s decision to reverse the USPTO’s conclusion (Director Rea) that the patent was unpatentable was made after finding that Leo Pharmaceutical’s invention solved the long-felt but unmet need of storage stability of the drug, which the prior art did not address. The Federal Circuit also found that the USPTO erred in its claim construction of “storage stable” in the reexamined patent claims. BSKB’s Andrew Meikle, Leonard Svensson, and Eugene Perez are among the representatives of Leo Pharmaceuticals Products Ltd. The inter partes reexamination control number is 95/000153 and was originally filed in 2006.

  • May 8, 2020

    BSKB Partner MaryAnne Armstrong Quoted in WIPR Article Regarding Alfred E. Mann Foundation for Scientific Research v. Cochlear Corp. Decision

    BSKB partner MaryAnne Armstrong, Ph.D., was quoted in a recent WIPR article regarding the Alfred E. Mann Foundation for Scientific Research v. Cochlear Corp. decision. In the article, Dr. Armstrong stated because “presumably the infringement has been spread” over about seven years, and that Cochlear reported revenues of about $750 million last year, the damages award might “not be so unreasonable” for Cochlear.

  • April 6, 2020

    LeBron Tries to Outmaneuver Charity Over ‘More Than An Athlete’

    LeBron James’ spat with a youth nonprofit over a simple t-shirt slogan is morphing into a complex trademark battle that could hinge on whether his acquisition of an earlier mark protects him from infringement charges.

  • April 6, 2020

    Intel, Apple Using Antitrust as New Weapon in Patent Fights

    Tech giants are testing the water of new legal theories It could subject non-practicing corporate entities to additional scrutiny Two Silicon Valley giants are testing a relatively new legal argument that non-practicing corporate entities that hoard patents and make aggressive demands can commit antitrust violations.

  • March 16, 2020

    Firm News – COVID-19

    Birch, Stewart, Kolasch & Birch, LLP (BSKB) is aware of the concerns about the spread of the Coronavirus (COVID-19). We are following the rapid developments and we are closely following the guidance of local health officials, the Centers for Disease Control and Prevention, and the World Health Organization to protect our employees, clients, and guests.

Contact Us